Free Trial

Minerva Neurosciences (NERV) SEC Filings & 10K Form

Minerva Neurosciences logo
$2.02 +0.04 (+1.76%)
Closing price 07/18/2025 03:49 PM Eastern
Extended Trading
$2.01 -0.02 (-0.74%)
As of 07/18/2025 05:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Minerva Neurosciences SEC Filings

DateFilerForm TypeView
05/13/2025
6:00 AM
Minerva Neurosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/21/2025
3:55 PM
Minerva Neurosciences (Filer)
Form 10-K/A
03/19/2025
3:43 PM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
5:30 AM
Minerva Neurosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/13/2025
7:46 AM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
4:45 PM
Luthringer Remy (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:45 PM
Minerva Neurosciences (Issuer)
Race Geoff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:45 PM
Ahlholm Frederick W (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:45 PM
HASLER HANS PETER (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:45 PM
Kupfer David (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:45 PM
Laghrissi-Thode Fouzia (Reporting)
Minerva Neurosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2024
4:45 PM
Minerva Neurosciences (Issuer)
VAN HEEK G JAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:21 PM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
6:00 AM
Minerva Neurosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2024
6:09 AM
Minerva Neurosciences (Filer)
Form DEFA14A
10/22/2024
6:12 AM
Minerva Neurosciences (Filer)
Form ARS
10/22/2024
6:06 AM
Minerva Neurosciences (Filer)
Form DEF 14A
10/11/2024
3:10 PM
Minerva Neurosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
6:01 AM
Minerva Neurosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NERV) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners